Quality key factors
Factor
Value
Sales Growth (5y)
3.65%
EBIT Growth (5y)
93.65%
EBIT to Interest (avg)
1.64
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
68.69
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.39%
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
446
Industry P/E
Price to Book Value
3.88
EV to EBIT
1375.63
EV to EBITDA
83.14
EV to Capital Employed
5.43
EV to Sales
8.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.39%
ROE (Latest)
0.87%
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for CF PharmTech, Inc
Depreciation
At HKD 34.79 MM has Grown at 14.17%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for CF PharmTech, Inc
Interest
At HKD 1.2 MM has Grown at 1,082.54%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Pre-Tax Profit
Fallen at -70.13%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (HKD MM)
Net Profit
Fallen at -71.87%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)






